Alcoholism and Schizophrenia: Diagnostic and Therapeutic Considerations (Q37684501)

22 August 2017

1 reference

title

Alcoholism and schizophrenia: diagnostic and therapeutic considerations (English)

1 reference

22 August 2017

Alcoholism and Schizophrenia: Diagnostic and Therapeutic Considerations (English)

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

1 January 2023

0 references

0 references

0 references

T. A. Ban

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:201179

1 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=201179

1 January 2023

publication date

1 April 1977

1 reference

full work available at URL

22 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111/j.1530-0277.1977.tb05855.x

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1530-0277.1977.tb05855.x/fullpdf

1 January 2023

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Alcoholism: Clinical and Experimental Research

1 January 2023

published in

1 reference

22 August 2017

volume

1

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

113-117

1 reference

Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Orthomolecular Psychiatry: Varying the concentrations of substances normally present in the human body may control mental disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Inhibition of ethanol-induced excitation in mice and rats by -methyl-p-tyrosine

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man.

1 January 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Effects and interactions of imipramine, chlorpromazine, reserpine and amphetamine on self-stimulation: possible neurophysiological basis of depression

1 January 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

1 January 2023

Federation Proceedings

10

23

836

Stein L.

1964

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 January 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Potentiation of phenothiazines by -methyltyrosine in treatment of chronic schizophrenia

1 January 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics

1 January 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Schizophrenia; a new approach. II. Result of a year's research

1 January 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Nicotinic acid and psychiatry

1 January 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Biochemistry of nicotinic acid and nicotinamide

1 January 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Controlled evaluation of nicotinamide adenine dinucleotide in the treatment of chronic schizophrenic patients

1 January 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

The behavioral effects of nicotinamide adenine dinucleotide in chronic schizophrenia

1 January 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

The intermediary metabolism of alcohol

1 January 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

1 January 2023

37

5

235

Manthel RW

1963

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Bulletin of the Los Angeles neurological societies

1 January 2023

38

29

158

Taylor J-A

1964

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

Metronidazole in the Treatment of the Alcoholic

1 January 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1530-0277.1977.TB05855.X

1 January 2023

Identifiers

1 reference

release_wp3winn6zbalvhybddcmg2cxiu

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wp3winn6zbalvhybddcmg2cxiu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference